IMMUNOTHERAPEUTIC METHODS USING ELECTROPORATION
Methods for treating tissue with irreversible electroporation and immunotherapy are described. The methods include placing a probe in tissue within a human body, wherein the probe has at least a first electrode, applying a plurality of electrical pulses through the first electrode and a second electrode, causing irreversible electroporation (IRE) of the tissue within a target ablation zone, and administering one or more exogenous agents into the tissue within the target ablation zone or to the human, thereby stimulating or otherwise modulating an immune system response within the body.
1 - 20 . (canceled)
21 . A method for treating tissue comprising:
placing a probe in tissue within a human body, wherein the probe has at least a first electrode;
applying a plurality of electrical pulses with the first electrode, wherein the electrical pulses have a pulse length of 1 second or less and there is a delay between two adjacent pulses, wherein the plurality of electrical pulses generates a substantially uniform electric field distribution;
causing pulsed electric field ablation of the tissue within a target ablation zone by causing cell death of at least some cells within the target ablation zone; and
administering one or more exogenous or endogenous agents into the tissue within the target ablation zone;
thereby stimulating or otherwise modulating an immune system response within the body.
22 . The method of claim 21 , wherein the plurality of electrical pulses are monophasic.
23 . The method of claim 21 , wherein the plurality of electrical pulses are biphasic.
24 . The method of claim 21 , wherein the plurality of electrical pulses have a square waveform
25 . The method of claim 21 , wherein the plurality of electrical pulses are applied in bursts of monopolar or bipolar pulses.
26 . The method of claim 21 , wherein the causing of pulsed electric filed ablation of the tissue includes altering transmembrane potential of the cells.
27 . A method for treating tissue comprising:
applying a plurality of electrical pulses with:
a pulse length of 1 second or less;
a frequency of 1 Hz-10 MHz; and
a voltage of at least 500 V;
wherein the applying of the plurality of electrical pulses causes irreversible disruption of a cellular membrane of cells within the tissue in an amount sufficient to promote an immune response within a body in a manner that causes death of metastases by way of immune cells that respond to the applied electrical pulses.
28 . The method of claim 27 , wherein the applying of the plurality of electrical pulses causes pulsed electric field ablation, reversible electroporation (RE), irreversible electroporation (IRE), electrochemotherapy (ECT), electrogenetherapy (EGT), or combinations thereof.
29 . The method of claim 27 , wherein the electrical pulses are monophasic.
30 . The method of claim 27 , wherein the electrical pulses are applied as a pulse train comprising bursts of pulses.
31 . The method of claim 30 , wherein the electrical pulses are applied with a delay between one or more pulses and/or between one or more bursts.
32 . The method of claim 27 , wherein one or more of the electrical pulses are biphasic and have a pulse length of 10 microseconds or less.
33 . The method of claim 27 , wherein at least two adjacent pulses are biphasic and comprise a delay of up to 5 times the pulse length between the adjacent pulses.
34 . The method of claim 33 , wherein the two adjacent pulses comprise a first pulse and a second pulse each with a pulse length of 10 microseconds or less.
35 . The method of claim 34 , wherein the delay is up to 5 microseconds, 10 microseconds, or 20 microseconds in length.
36 . The method of claim 27 , wherein the immune response is promoted by immune cells present in a first target ablation zone.
37 . The method of claim 26 , wherein
the immune response is promoted by immune cells present in a second zone disposed in a region beyond the first zone.
38 . The method of claim 26 , wherein the immune response is promoted by immune cells present in the first target ablation zone and a second zone disposed in a region beyond the first zone.
39 . The method of claim 26 , wherein a second zone is disposed beyond the first zone and a different immune response occurs in the second zone as compared with that in the first zone.
40 . A method for treating tissue comprising:
generating a plurality of electrical pulses with a pulse length of 1 second or less, a frequency of 1 Hz-10 MHz, and a voltage of at least 500 V; and
applying the electrical pulses to tissue in a first target ablation zone in an amount sufficient to cause non-thermal ablation of cells and to promote an immune response within a body in a manner that causes death of metastases by way of immune cells that respond to the applied electrical pulses;
wherein the immune response is promoted by immune cells present in the first target ablation zone.